Luigi B.
- Country
- Italy
- Department
- SC Nefrologia, Dialisi e Trapianto
Research Overview
- Frexalimab Versus Tacrolimus for Prevention of Kidney Graft Rejection in Adult Kidney Transplant Recipients
- Phase 2 Study of Empasiprubart in Deceased Donor Renal Allograft Recipients at Risk for Delayed Graft Function
- A multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (LNP023) in idiopathic immune complex mediated membranoproliferative glomerulonephritis (IC-MPGN)
Data & Insights
Has run more than one trial at 176 of 409 partner sites.
Specializations
Kidney Transplantation
This investigator specializes in managing deceased donor kidney transplants with particular focus on preventing and treating delayed graft function. Their research explores innovative therapeutic approaches to improve allograft outcomes.
- Transplant Immunology
- Graft Function Optimization
- Post-transplant Care
Their work extends to evaluating novel immunological interventions in transplant recipients.
Chronic Kidney Disease Management
The investigator focuses on treating chronic kidney disease with concurrent hypertension. Their expertise includes evaluation of combination therapies to slow CKD progression and manage associated complications.
- Blood Pressure Control
- Renal Function Preservation
- Proteinuria Management
Their research encompasses innovative approaches to kidney function preservation and cardiovascular risk reduction.
Glomerular Diseases
The investigator has significant expertise in treating complex glomerular conditions, including IC-MPGN and IgA Nephropathy. Their work focuses on novel therapeutic approaches for these challenging renal disorders.
- Proteinuria Reduction Strategies
- Immune-mediated Kidney Diseases
- Novel Therapeutic Applications
Their research includes evaluation of targeted therapies for specific glomerular pathologies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.